Table 4.
Sex | Age | Professional experience | ||||||
---|---|---|---|---|---|---|---|---|
Beta† | P | Beta† | P | Beta† | P | Adjusted R 2 | ANOVA P | |
Medical education program for the ‘Treatment Guideline for Pharmacological Therapy for Schizophrenia’ | ||||||||
Total clinical knowledge score at baseline | −0.05 | 0.33 | −0.12 | 0.14 | 0.18 | 2.5 × 10−2 | 0.019 | 8.7 × 10−2 |
Total clinical knowledge score after the program | −0.05 | 0.38 | −0.18 | 2.9 × 10−2 | 0.15 | 0.06 | 0.008 | 0.13 |
Medical education program for ‘Treatment Guideline II: Major Depressive Disorder’ | ||||||||
Total clinical knowledge score at baseline | −0.06 | 0.26 | −0.22 | 5.0 × 10 −3 | 0.41 | 2.6 × 10 −7 | 0.081 | 6.0 × 10 −7 |
Total clinical knowledge score after the program | −0.02 | 0.79 | −0.21 | 8.0 × 10 −3 | 0.35 | 1.6 × 10 −5 | 0.048 | 1.8 × 10 −4 |
Standardized partial regression coefficient.
The significance level was set at two‐tailed P < 1.25 × 10−2 as the Bonferroni method was applied.
Significant P‐values are boldfaced.
ANOVA, analysis of variance.